|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 135.87 USD | -1.29% |
|
-2.27% | +10.70% |
| 04-20 | Arcus Biosciences Discontinues Phase 3 Lung Cancer Trial for Futility | MT |
| 04-20 | Arcus Biosciences Discontinues Lung Cancer Trial With Gilead | DJ |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 2.42% | 2.47% | 18.45x | 6.1x | 5.77x | 10.62x | 12.49x | 169B | ||
| 0.73% | 0.82% | 27.06x | 16.88x | 10.25x | 20.54x | 22.37x | 823B | ||
| 2.31% | 2.41% | 24.65x | 6.21x | 5.69x | 15.4x | 17.09x | 556B | ||
| 3.38% | 3.51% | 22.92x | 136.46x | 6.15x | 12.48x | 12.89x | 360B | ||
| 3.12% | 3.21% | 17.23x | 6.03x | 4.24x | 10.43x | 11.77x | 330B | ||
| 1.64% | 1.74% | 25.53x | 5.63x | 5.27x | 14.89x | 15.73x | 314B | ||
| 2.88% | 2.98% | 28.16x | 5.14x | 4.83x | 15x | 17.82x | 289B | ||
| 2.9% | 3.04% | 21.08x | 6.36x | 5.65x | 13.68x | 14.96x | 290B | ||
| 2.88% | 3.08% | 23.01x | 16.74x | 6.08x | 10.7x | 13.81x | 189B | ||
| 4.23% | 4.34% | 12.22x | 5.17x | 4.39x | 9.18x | 10.8x | 180B | ||
| 6.37% | 6.35% | 12.5x | 1.77x | 3.3x | 7.95x | 9.29x | 157B | ||
| 4.27% | 4.4% | 12.06x | 5.13x | 3.16x | 8.32x | 9.12x | 121B | ||
| 5.19% | 5.51% | 12.09x | 1.29x | 2.37x | 7.62x | 8.53x | 117B | ||
| 3.26% | 3.54% | 13.56x | 4.44x | 2.88x | 8.46x | 9.53x | 116B | ||
| -.--% | -.--% | 25.22x | 4.96x | 7.58x | 17.08x | 17.73x | 112B | ||
| 1.55% | 1.72% | 28.74x | 6.41x | 9.85x | 18.52x | 19.37x | 91.79B | ||
| 3.59% | 3.65% | 49.61x | 1.24x | 2.81x | 10.38x | 29.44x | 55.54B | ||
| 0.48% | 0.55% | 40.1x | 5.39x | 9.09x | 30.31x | 31.7x | 54.82B | ||
| 0.52% | 1.7% | 20.66x | 1.45x | 1.61x | 7.72x | 13.26x | 47.88B | ||
| 2.22% | 2.46% | 18.45x | 1.85x | 3.38x | 12.75x | 14.31x | 42.93B | ||
| Average | 2.7% | 2.87% | 22.67x | 12.23x | 5.22x | 13.10x | 15.60x | 220.74B | |
| Weighted average by Cap. | 2.5% | 2.62% | 22.75x | 18.56x | 6.10x | 14.21x | 15.98x |
- Stock Market
- Equities
- GILD Stock
- Sector Gilead Sciences, Inc.
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















